InvestorsHub Logo
Followers 88
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: rakp post# 5883

Monday, 03/12/2018 9:04:46 AM

Monday, March 12, 2018 9:04:46 AM

Post# of 64154
Agreed

The patent process covering the nanoemulsion was started in July 2015. The patent was granted on June 2017. The nanoelmulsion was developed during this period .
The patent title is :
Augmentation of oncology immunotherapies by pterostilbene containing compositions

The last word of the title is plural , not singular , so there is the possibility of other products being developed.
TSI focused on the nanoemulsion , and there aren't that many nanoemulsions out there . It is a unique way of drug delivery .

The financials could be better . They were 3 years behind on their filings , and managed to catch up at the end of last year to become fully reporting , but then slipped back onto the pinks .
Last year's annual , and last quarter financials are not filed .
At this point in time , there has been no toxic funding that I know of , and the company has managed to keep moving along in their product development.

It's a Bio startup , so it can be a longer road to success , as it takes time to go though the R and D process .

With every stock ,doing the DD is important in finding a low entry point.
Play it as you see it , and GLTA .
-Cents













Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News